CTA
ZBH icon

Carillon Tower Advisers’s Zimmer Biomet ZBH Stock Holding History

Carillon Tower Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$3.02M Sell
20,188
-721
-3% -$102K 0.02% 444
2020
Q3 		$2.76M Sell
20,909
-1,648
-7% -$215K 0.04% 390
2020
Q2 		$2.61M Sell
22,557
-1,236
-5% -$142K 0.02% 420
2020
Q1 		$2.33M Buy
23,793
+4,429
+23% +$581K 0.02% 393
2019
Q4 		$2.81M Buy
+19,364
New +$2.67M 0.02% 441

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Carillon Tower Advisers's ZBH Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Zimmer Biomet (ZBH) stake by 3.4% in Q4 2020, selling an estimated $102K and leaving 20,188 shares worth $3.02M. The position accounts for 0.02% of the portfolio, ranked #444.

Carillon Tower Advisers first reported a position in ZBH in Q4 2019 and has held it in 5 quarters since. 1,012 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Carillon Tower Advisers held 20,188 shares of Zimmer Biomet worth $3.02M as of Q4 2020.
  • Carillon Tower Advisers sold 721 Zimmer Biomet shares in Q4 2020, an estimated $102K.
  • Zimmer Biomet made up 0.02% of Carillon Tower Advisers's portfolio in Q4 2020, its #444 holding.
  • Carillon Tower Advisers first reported a position in Zimmer Biomet in Q4 2019 and has held it in 5 quarters since.
  • 1,012 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.